I. Cavero

I. Cavero, J. Buckley, H. Smookler, 1973, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Effects of prolonged hydrochlorothiazide administration on neurogenic tone in the hind limb vasculature.

I. Cavero, J. Buckley, B. Jandhyala, 1972, European journal of pharmacology.

Studies on the mechanism of the vasodilator effects of prazosin in dogs and rabbits.

A. Roach, R. Gomeni, I. Cavero, 1978, European journal of pharmacology.

Cardiovascular effects of prazosin in dogs.

I. Cavero, 1976, Clinical science and molecular medicine. Supplement.

Differential inhibition of vascular smooth muscle responses to alpha 1- and alpha 2-adrenoceptor agonists by diltiazem and verapamil.

S. Z. Langer, N. Shepperson, I. Cavero, 1983, Circulation research.

[The prevalence, risk factors and clinical significance of atherosclerosis of the thoracic aorta: a transesophageal echocardiographic study].

I. Cavero, Guillon Jm, 1993 .

Membrane ion channels and cardiovascular ATP-sensitive K+ channels.

J. Guillon, I. Cavero, 1993, Cardiologia.

Influence of pentobarbital anesthesia on the effects of certain autonomic blocking agents on heart rate.

I. Cavero, J. Buckley, M. Lokhandwala, 1973, European journal of pharmacology.

Hemodynamic and myocardial effects of (-)-delta9-trans-tetrahydrocannabinol in anesthetized dogs.

I. Cavero, J. Buckley, B. Jandhyala, 1973, European journal of pharmacology.

Cellular pharmacology of potassium channel openers in vascular smooth muscle.

U. Quast, J. Guillon, I. Cavero, 1994, Cardiovascular research.

The development of glutamate-based antidepressants is taking longer than expected.

P. Skolnick, Yong-Ku Kim, I. Cavero, 2018, Drug discovery today.

Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats.

H. Lippton, I. Cavero, A. Hyman, 1990, The Journal of pharmacology and experimental therapeutics.

Antagonistic effects of epinephrine, glucagon and methylatropine but not calcium chloride against atrio‐ventricular conduction disturbances produced by high doses of diltiazem, in conscious dogs

I. Cavero, J. Sabatier, T. Pouyet, 1991, Fundamental & clinical pharmacology.

14th Annual Meeting of the Safety Pharmacology Society: Threading through peripheral and central nervous system presentations.

Icilio Cavero, Henry Holzgrefe, I. Cavero, 2015, Journal of pharmacological and toxicological methods.

Increase in plasma renin activity evoked by fenoldopam in dogs is directly mediated by dopamine1 receptor stimulation.

I. Cavero, J. Pratz, F. Montier, 1989, Journal of cardiovascular pharmacology.

The effects of prazosin on the clonidine induced hypotension and bradycardia in rats and sedation in chicks [proceedings].

A. Roach, I. Cavero, 1978, British journal of pharmacology.

Comprehensive in vitro Proarrhythmia Assay (CiPA): Pending issues for successful validation and implementation.

Jean-Frédéric Gerbeau, Mike Clements, Icilio Cavero, 2016, Journal of pharmacological and toxicological methods.

Promises and partnership: FDA's Critical Path Initiative and its intersection with pharmacology: an ASPET 2011 annual meeting symposium

I. Cavero, 2011 .

The myocardial lesions produced by the potassium channel opener aprikalim in monkeys and rats are prevented by blockade of cardiac beta-adrenoceptors.

T. Hodge, R. Jordan, G. Nohynek, 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

10th annual meeting of the Safety Pharmacology Society: an overview

I. Cavero, 2011, Expert opinion on drug safety.

Comparison of Cardiovascular Actions of Dihydralazine, Phentolamine, and Prazosin in Spontaneously Hypertensive Rats

A. Roach, I. Cavero, F. LEFÈVRE‐BORG, 1979, Journal of cardiovascular pharmacology.

Safety Pharmacology assessment of drugs with biased 5-HT(2B) receptor agonism mediating cardiac valvulopathy.

Icilio Cavero, Jean-Michel Guillon, J. Guillon, 2014, Journal of pharmacological and toxicological methods.

Heart rate lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of central dopamine receptors leading to inhibition of sympathetic tone and enhancement of parasympathetic outflow.

R. Gomeni, I. Cavero, F. Lefèvre-Borg, 1981, The Journal of pharmacology and experimental therapeutics.

Mechanism of Antihypertensive Activity of Orally Administered Prazosin in Spontaneously Hypertensive Rats

A. Roach, I. Cavero, F. LEFÈVRE‐BORG, 1979, Journal of cardiovascular pharmacology.

The arterial wall: a new pharmacological and therapeutic target *

J. Elghozi, B. Dupuis, J. Elghozi, 1995, Fundamental & clinical pharmacology.

19th Annual Meeting of the Safety Pharmacology Society: regulatory and safety perspectives for advanced therapy medicinal products (cellular and gene therapy products)

W. Zimmermann, D. Seimetz, I. Cavero, 2020, Expert opinion on drug safety.

The effect of (minus)-delta 9-trans-tetrahydrocannibinol on myocardial contractility and venous return in anesthetized dogs.

I. Cavero, J. Buckley, M. Lokhandwala, 1974, European journal of pharmacology.

[Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval].

V. Calderone, I. Cavero, 2002, Minerva medica.

18th Annual Meeting of the Safety Pharmacology Society: drug safety assessment on gastrointestinal system functions

I. Cavero, H. Holzgrefe, 2019, Expert opinion on drug safety.

18th world congress of basic and clinical pharmacology: thought-provoking lectures on drug safety issues

I. Cavero, H. Holzgrefe, 2019, Expert opinion on drug safety.

96 Studies on the mechanism of PAF-evoked fibrinolysis activation

P. Sedivy, I. Cavero, 1988 .

ICH S7B draft guideline on the non-clinical strategy for testing delayed cardiac repolarisation risk of drugs: a critical analysis

Icilio Cavero, W. Crumb, I. Cavero, 2005, Expert opinion on drug safety.

"Calcium antagonists": a class of drugs with a bright future. Part I. Cellular calcium homeostasis and calcium as a coupling messenger.

M. Spedding, I. Cavero, 1983, Life sciences.

Effects of prazosin on reflex changes in heart rate evoked by vasopressor and vasodepressor stimuli in conscious rabbits.

I. Cavero, 1982, Journal of cardiovascular pharmacology.

Systemic and regional hemodynamic characterization of alpha-1 and alpha-2 adrenoceptor agonists in pithed rats.

C. Gomeni, R. Gomeni, J. Lechaire, 1987, Journal of Pharmacology and Experimental Therapeutics.

SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.

K. Lawson, I. Cavero, C. Thiry, 1991, Journal of Pharmacology and Experimental Therapeutics.

Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.

F. Lhoste, J. Giudicelli, I. Cavero, 1984, The Journal of pharmacology and experimental therapeutics.

Role of the sympathetic nervous system in blood pressure maintenance and in the antihypertensive effects of calcium antagonists in spontaneously hypertensive rats.

I. Cavero, F. Lefèvre-Borg, O. Mathias, 1988, Hypertension.

Sleeping times evoked by alpha adrenoceptor agonists in two-day-old chicks: an experimental model to evaluate full and partial agonists at central alpha-2 adrenoceptors.

A. Roach, I. Cavero, J. Doxey, 1983, The Journal of pharmacology and experimental therapeutics.

Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.

B. Scatton, F. Lhoste, J. Lorrain, 1985, Journal of Pharmacology and Experimental Therapeutics.

Studies on the mechanisms of the development of tolerance to the hypotensive effects of fenoldopam in rats.

J. Lechaire, J. Lorrain, I. Cavero, 1988, Journal of cardiovascular pharmacology.

13th Annual Meeting of the Safety Pharmacology Society: focus on novel technologies and safety pharmacology frontiers

Icilio Cavero, I. Cavero, 2014, Expert opinion on drug safety.

Drug discovery paradigms: past, present, future – a centennial symposium of the American Society for Pharmacology and Experimental Therapeutics

I. Cavero, H. R. Kaplan, 2008, Expert opinion on drug discovery.

Evidence for the existence and ionic modulation of platelet-activating factor receptors mediating degranulatory responses in human polymorphonuclear leukocytes.

I. Cavero, C. Robaut, O. Marquis, 1989, Journal of Pharmacology and Experimental Therapeutics.

Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.

A. Roach, B. Scatton, R. Gomeni, 1982, The Journal of pharmacology and experimental therapeutics.

Evaluation of the Rabbit Purkinje Fibre Assay as an in vitro Tool for Assessing the Risk of Drug-Induced Torsades de Pointes in Humans

Björn Wagner, Isabelle Parrilla, Icilio Cavero, 2006, Drug safety.

Validation of a novel technique allowing assessment of the functional role of cardiac prejunctional receptors in the rat.

I. Cavero, C. Thiry, 1990, Journal of autonomic pharmacology.

A differential effect of chronically administered guanethidine on sympathetic neurotransmission to the dog heart and mesenteric arterial blood vessels.

D. Clarke, I. Cavero, J. Buckley, 1974, Canadian journal of physiology and pharmacology.

14th Annual Meeting of the Safety Pharmacology Society: threading through scientific sessions for originality and novelty

Icilio Cavero, I. Cavero, 2015, Expert opinion on drug safety.

High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.

I. Cavero, S. Mondot, A. Floch, 1988, Molecular pharmacology.

Aspects of Potassium Channel Modulation

O. Pongs, G. Kaczorowski, U. Quast, 1995 .

QT interval prolongation by non-cardiovascular drugs: issues and solutions for novel drug development.

Cavero, W. Crumb, I. Cavero, 1999, Pharmaceutical science & technology today.

CiPA: Ongoing testing, future qualification procedures, and pending issues.

Icilio Cavero, Henry Holzgrefe, I. Cavero, 2015, Journal of pharmacological and toxicological methods.

Differential Inhibition of Vascular Smooth Muscle Responses to α1‐ and α2‐Adrenoceptor Agonists by Diltiazem and Verapamil

S. Z. Langer, N. Shepperson, I. Cavero, 1983 .

Stimulation of peripheral dopamine receptors in rats: a mechanism for novel antihypertensive agents.

I. Cavero, F. Lefèvre-Borg, 1980, Clinical science.

RP 55778, a PAF receptor antagonist, prevents and reverses LPS-induced hemoconcentration and TNF release.

A. Bousseau, F. Floc’h, I. Cavero, 1989, Journal of lipid mediators.

Safety Pharmacology Society: 7th Annual Meeting

I. Cavero, 2008 .

Effects of the K+ channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats.

I. Cavero, J. Pratz, S. Mondot, 1991, The Journal of pharmacology and experimental therapeutics.

Patch‐Clamp Studies of Human Cardiac Ion Channels in the Evaluation of Cardiac Electrophysiological Effects of Compounds

W. Crumb, I. Cavero, 2003, Current protocols in pharmacology.

Drugs that prolong QT interval as an unwanted effect: assessing their likelihood of inducing hazardous cardiac dysrhythmias

W. Crumb, J. Guillon, I Cavero, 2000, Expert opinion on pharmacotherapy.

Safety Pharmacology Society: 5th Annual Meeting

W. Crumb, I. Cavero, 2006, Expert opinion on drug safety.